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Background: While several anti-malarials are known to affect the electric conduction system of the heart, less is
known on the direct effects of Plasmodium falciparum infection. Some earlier studies point to a direct impact of
Plasmodium falciparum infection on the electric conduction system of the heart. The aim of this study was to analyse
infection- and drug-induced effects on the electric conduction system.
Methods: Children aged 12 months to 108 months with severe malaria were included in Kumasi, Ghana. In
addition to basic demographic, clinical, biochemical and parasitological, biochemical data were measured data
upon hospitalization (day 0) and 12-lead electrocardiograms were recorded before (day 0) and after (day 1) initiation of
quinine therapy as well as after 42 (±3) days.
Results: A total of 180 children were included. Most children were tachycardic on day 0 but heart rate declined on day
1 and during follow up. The corrected QT intervals were longest on day 1 and shortest on day 0. Comparison of QT
intervals with day 42 (healthy status) after stratification for age demonstrated that in the youngest (<24 months) this
was mainly due to a QT shortage on day 0 while a QT prolongation on day 1 was most pronounced in the oldest
(≥48 months). Nearly one third of the participating children had measurable 4-aminoquinoline levels upon admission,
but no direct effect on the corrected QT intervals could be shown.
Conclusion: Severe P. falciparum infection itself can provoke changes in the electrophysiology of the heart,
independent of anti-malarial therapy. Especially in young - thus non immune - children the effect of acute disease
associated pre-treatment QT-shortage is more pronounced than quinine associated QT-prolongation after therapy.
Nevertheless, neither malaria nor anti-malarial induced effects on the electrophysiology of the heart were associated
with clinically relevant arrhythmias in the present study population.
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The systematic assessment of the effect of severe Plasmo-
dium falciparum infection on the electric conduction
system of the heart is incomplete. Like other febrile
diseases, malaria increases the sympathetic tone in patients,
leading to an acceleration of the electric conduction
and repolarization of the heart, which can be shown as
shortening of the QT intervals in electrocardiographic
recordings [1]. However, some studies point to a direct
impact of P. falciparum infection on the electric conduc-
tion system of the heart, which belongs to one of the most
severely parasitized organs in humans [2]. Von Seidlein
et al., for example, found a correlation between para-
sitaemia and corrected QT prolongation in Gambian
children with uncomplicated falciparum malaria [3].
Another study on 161 patients with P. falciparum malaria,
found abnormal ECG findings in 14.3 per cent of all
patients, including T-segment or T-wave alterations in
15 patients and delayed conduction in eight patients [4].
Other studies and case reports point to a rare occur-
rence of adverse cardiac events during the course of
severe malaria infection [5-7].
In addition to potential malaria-related effects, several
drugs used for the treatment of P. falciparum malaria,
such as quinine and halofantrine, are associated with an
alteration of the electrophysiology of the heart, in particu-
lar provoking QT prolongation [8,9]. This iatrogenic effect
has to be accounted for in order to separate malarial
and chemotherapeutic effects on the electric conduction
system of the heart in severe malaria. As arrhythmias are
seldom recognized in children with severe malaria, it is
unclear whether or not electrocardiographic alterations
are of relevant clinical significance.
This study was designed to measure intra-individual
ECG changes at three major points: Day 0 representing
malaria without drug effects, day 1 representing malaria
and drug effects as well as day 42 representing the
healthy status without malaria and anti-malarial drugs.
In addition, potential influence of pre-hospitalization
medications, age as well as signs and symptoms defining
severe malaria on cardiac electrophysiology were assessed.
Methods
The study was conducted at the Paediatric Emergency
Unit of the Komfo Anokye Teaching Hosptial (KATH) in
Kumasi, Ghana, between March 2009 and October 2009.
After written consent was obtained by parents or legal
guardians children aged 12 months to 108 months with
signs of severe malaria and a positive rapid diagnostic test
(OptiMAL®) were screened. Severe malaria was defined as
presence of asexual blood stage parasites, symptoms and
conditions according to WHO criteria [10] and by the ab-
sence of alternative causes for febrile illness. Metabolic
acidosis was defined as base excess < −8.On admission (day 0) the patients were clinically
examined and parameters, such as blood pressure,
heart rate, respiratory rate as well as body temperature
were recorded and signs of severe malaria were ascer-
tained. Patients were treated with parenteral quinine
according to national guidelines (20 mg/kg loading
dose followed by 10 mg/kg twice daily) for seven days
or until they were able to receive orally administrated
artemether-lumefantrine. Patients were followed-up on
days 1 and 42 (±3).
A standard 12-lead electrocardiogram (ECG) was con-
ducted on day 0 before the start of quinine therapy, on
day 1 after treatment initiation and on day 42. ECGs
were recorded at a chart rate of 50 mm/sec. All ECG
results were printed, scanned and reviewed using the
software GraphicConverter X (Version 6.7.3). An elec-
tronic ruler was used to measure RR, PQ, QRS, and QT.
To minimize variability due to lead selection, QT-intervals
in lead II and V5 were measured and the longer interval
was selected for further analysis [11,12]. U-waves were not
included in the measurement of the T wave [13]. The QT
interval was corrected for heart rate using two different
formula, (i) the Bazett formula [14], labelled cQT; and (ii)
the Wernicke formula [15], labelled hQT. For subsequent
statistical analysis, the formula developed by Wernicke
et al. was chosen as it more effectively removes the rate
dependence of the adjusted QT in children [11]. For
comparability with other studies, selected data was also
presented according to the Bazett formula.
Blood samples were taken on day 0 and on day 42.
Plasmodium falciparum malaria was ascertained from
Giemsa-stained thick and thin films. Blood chemistry
parameters were measured by the I-STAT® analysing
system including but not limited to creatinine, glucose, pH,
lactate and base excess. Concentrations of 4-aminoquinoline
drugs (chloroquine, N-desethyl-chloroquine, amiodiaquine,
N-desethyl-amiodiaqine) were determined from urine sam-
ples obtained on day 0 using high-performance liquid
chromatography (HPLC) with ultra-violet (UV) detection.
The method has already been published with some minor
deviations [16]. In brief, isocratic HPLC was performed
using 87% TEMED-buffer (tetramethylethylenediamine,
10 mM adjusted to pH 3.5 by phosphoric acid) and 13%
acetonitrile as eluent on a Phenomenex Luna C18 column.
The flow rate was 1 ml/min and the column was heated
to 40°C. The injection volume was 50 μL and the ana-
lytes were detected at the UV wavelength of 340 nm.
Urine samples were diluted with HPLC eluent (20 μL
urine + 1,480 μL eluent containing 4-((7-chloro-4-qui-
nolinyl)amino)-1-pentanol, an amodiaquine analogue, as
internal standard) and analyzed by HPLC. Calibrations
in urine were done in the range of 3.0–250 μg/mL for
all four analytes. The lower limit of quantification was
3.0 μg/mL. The method was validated according to the
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within the FDA accepted range of +/−15%.
The study was approved by the ethics committee of
the Kwane Nkrumah University of Science and Tech-
nology (KNUST), Kumasi. Statistics software SPSS 18.0
was used to analyse data. Statistical significance was
defined a p < 0.05. Dependent t-test (pair-wise analysis)
was used for comparing findings between day 0, day 1
and day 42. Independent t-test was used to analyse
differences in ECG parameters in subgroups.
Results
Baseline characteristics
Severe malaria was ascertained and complete day 0-data
sets were available for 180 (82%) of 220 initially screened
children, 103 (57%) were males. The median age was
36 months (range 12 to 108 months), 125 of the 180 (70%)
children were available for follow up ECG assessment on
day 42. Criteria for severe malaria were prostration (158
cases), multiple convulsions (94 cases), hyperlactataemia
(63 cases), jaundice (55 cases), metabolic acidosis (55
cases), hyperparasitaemia (53 cases), coma (50 cases),
severe anaemia (41 cases), haemoglubinuria (36 cases), re-
spiratory distress (22), circular collapse (14), hypoglycaemia
(10 cases), renal impairment (3 cases) and abnormal
bleeding (1 case). Five children (3%) died. Demographic,
clinical and biochemical characteristics are shown in
Table 1.
ECG findings
Most children had moderate to severe tachycardia on
day 0 but heart rates (HR) declined on day 1 and during
follow up (Table 2). The corrected overall QT time
(hQT) was significantly prolonged on day 1 and shortest
on day 0. QRS complex was significantly longer on day 1
compared to day 0, while there was no significant differ-
ence between day 0 and 42. The PQ intervals wereTable 1 Demographic, clinical and biochemical characteristics
day 1 and day 42
Characteristics Day 0 n = 18
Age (months, median (± interquartile range)) 36 (±26.5)
Male gender (%) 103 (57)
Temperature (°C) 37.4 (±1.2)
Parasite density (per μl) 33.804 (±15.6
Respiratory rate (per min) 45.5 (±13.8)
pH 7.42 (±0.1)
Leukocytes (per μl) 12.3 (±8.5)
Lactate (mmol/l) 5.2 (±4.2)
Glucose (mg/dl) 107.4 (±49.1)
Creatinine (mg/dl) 0.69 (±1.1)
Values are means (±SD) if not indicated otherwise, paired t-test.significantly longer day 1 than on day 0 and during follow
up. Comparing hQT and cQT showed overall shorter hQT
intervals than cQT intervals (Table 2).
For a stratified analysis of the effect of age on ECG
parameters, children were divided intro three age groups
(<24 months, 24 to <48 months, ≥48 months, Figure 1A
and B) on the day of admission. On day 0, HR decreased
and hQT increased with age. During the course of
disease and follow up, HR decreased over time in all age
groups. All age groups showed elevated hQT intervals
on day 1 compared to day 0. The hQT intervals in the
age group <24 months, were comparable between day 1
and day 42, but significantly shorter on day 0, in the age
groups of children 24 months and older, in contrast, the
hQT intervals on day 42 were comparable with day 0.
The age stratified analysis of the QRS complex revealed
that there was only a significant prolongation of QRS on
day 1 compared to day 0 in the age group 24 to <48 months
(61 vs. 57 ms, p =0.002).
Of the 153 cases in which urine concentrations of
4-aminoquinoline drugs were measured on the day of
admission 50 (33%) were positive for one or more than
one of these drugs. (N-desethyl)-chloroquine was detect-
able in 28 of the 50 cases (56%), (N-desethyl-) amiodia-
quine was detectable in 37 of the 50 cases (74%), thus 15
cases (30%) were positive for (N-desethyl-) chloroquine
and (N-desethyl-) amiodiaquine.
HR was significantly slower in children who had taken
4-aminoquinolines prior to admission compared to those
who had not (136 vs. 145, p = 0.048). There was no sig-
nificant difference in the mean of hQT between children
with or without 4-aminoquinoline levels (Table 3).
The effect of the pre-hospitalization intake of 4-
aminoquinolines was further stratified on hQT according
to age (Figure 1C and D). In the subgroup of 4-
aminoquinoline naïve children, the hQT intervals were
longer on day 1 compared to day 0 in all age groups.in children with severe malaria on day 0,











Table 2 Electrocardiographic findings on day 0, 1 and 42
Electrocardiographic findigs Day 0 n = 164 Day 1 n = 164 Day 42 n = 126 P value day 1:0 P value day 42:0 P value day 42:1
HR (per minute) 143 (±27) 123 (±23) 106 (±30) <0.001 <0.001 <0.001
PQ (ms) 121 (±19) 136 (±18) 131 (±20) <0.001 <0.001 <0.001
QRS (ms) 58 (±12) 63 (±23) 57 (±11) 0.016 0.535 0.048
hQT (ms, Wernicke) 381 (±32) 405 (±32) 390 (±25) <0.001 0.021 0.001
cQT (ms, Bazett) 422 (±32) 442 (±33) 419 (±27) <0.001 0.090 <0.001
Values are means (±SD) if not indicated otherwise, paired t-test.
Figure 1 HR and hQT stratified by age groups (<2 years, 2 to <4 years, ≥ 4). Heart rate and hQT stratified by age group (<2 years, 2 to
<4 years, ≥ 4 years) upon hospitalization in relation to day 1 and day 42: A heart rate, B hQT, C hQT for children with positive urine sample of
4-aminoquinoline drugs, D hQT for children without positive urine sample of 4-aminoquinoline drugs. The boxplots display medians and
interquartile ranges. The age groups were compared by t-test: *P < 0.05, **P < 0.005, ***P < 0.001, ns not significant.
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Table 3 hQT time on day 0, 1 and 42 for children with and without positive urine sample of 4-aminoquinoline drugs






4-aminoquinoline drugs negative 379 (±30) (n = 91) 408 (±32) (n = 91) 392 (±26) (n = 71) <0.001 0.018 <0.001
4-aminoquinoline drugs positive 386 (±32) (n = 50) 401 (±32) (n = 50) 390 (±25) (n = 36) <0.001 0.452 0.04
P value2) negative: positive 0.093 0.262 0.299
Values are means (±SD) if not indicated otherwise. There was no difference in age between both groups.
1)Paired t-test.
2)Unpaired t-test.
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day 42, but significantly shorter on day 0 in the youngest,
while in the age groups of children 24 months and older
hQT on day 42 was comparable to day 0 (Figure 1D). In
the subgroup of children treated with 4-aminoquinolines
prior to admission, there was still a trend of longer hQT
on day 1 but there was only a significant difference in
hQT on day 0 compared to day 1 in the oldest age group
(Figure 1C). Nevertheless, there was no significant differ-
ence in the mean of hQT intervals between children who
had taken 4-aminoquinolines prior to admission compared
to those who had not in any age group on day 0 (<2 years:
380 ms versus 353 ms p = 0.051, 2 to <4 years: 352 ms vs
345 ms p = 0.808, ≥4 years 399 ms vs 381 ms p = 0.374).
To further understand the influence of P. falciparum
infection on the conduction system of the heart, the im-
pact of severe malaria defining conditions on heart rateTable 4 HR and hQT stratified according to severe malaria-de
parameters on day 0
Signs day 0 No. (%) H
With sign
Clinical
Coma 48/177 (27) 144 (±25)
Prostration 155/177 (88) 142 (±28)
Multiple convulsions (per 24 h) 92/177 (52) 141 (±26)
Respiratory Distress 22/177 (12) 152 (±40)
Jaundice 53/177 (30) 137 (±23)
Haemoglubinuria 36/175 (21) 136 (±25)
Circularly collapse 14/178 (8) 147 (±21)
Laborator
Hypoglycaemia 10/177 (5) 140 (±51)
Metabolic acidosis (BE < −8) 55/171 (32) 152 (±32)
Severe anaemia (Hb < 5 g/dl) 41/164 (25) 149 (±35)
Hyperparasitaemia 53/177 (30) 151 (±21)
Hyperlactataemia (>5 mmol/l) 63/172 (37) 155 (±28)
Renal impairment (creatinine >3 mg/dl) 3/163 (2) 106 (±31)
Additional pa
Male gender 102/177 (58) 141 (±30)
Capillary refill time ≥ 3 s 17/177 (10) 135 (±42)
Values are means (±SD) if not indicated otherwise, unpaired t-test.and hQT intervals upon hospitalization was analysed
(Table 4): HR was significantly elevated in children with
metabolic acidosis, hyperlactataemia (>5 mmol/l) as well
as hyperparasitaemia compared to children without these
characteristics. Children with renal impairment had
significantly lower heart rates than those without. A
significantly shorter hQT was shown in patients with
metabolic acidosis and with conditions related to meta-
bolic acidosis such as hyperlactataemia and respiratory
distress. Forty-three of 63 patients (68%) with hyperlac-
tataemia and 18 of 22 (88%) patients with respiratory
distress also had metabolic acidosis. The hQT was also
significantly shorter in patients with prostration. Patients
with jaundice and those with haemoglobinuria had a
significantly prolonged hQT (Table 4). There was no influ-
ence of hypoglycaemia or hyperparasitaemina on hQT
intervals (Table 4).fining sings and symptoms and selected additional
R (per min) hQT (ms, Wernicke)
Without sign P value With sign Without sign P value
signs
142 (±28) 0.688 381 (±34) 381 (±30) 0.996
142 (±23) 0.983 379 (±34) 396 (±28) 0.025
143 (±28) 0.617 381 (±37) 381 (±30) 0.967
141 (±25) 0.069 360 (±40) 384 (±31) 0.002
144 (±28) 0.086 391 (±34) 377 (±30) 0.010
144 (±28) 0.147 391 (±34) 379 (±32) 0.046
143 (±25) 0.506 384 (±34) 381 (±33) 0.700
y signs
142 (±25) 0.805 375 (±20) 381 (±34) 0.595
137 (±23) <0.001 367 (±32) 388 (±32) <0.001
140 (±24) 0.052 383 (±33) 373 (±33) 0.089
138 (±28) 0.002 374 (±29) 384 (±35) 0.086
134 (±24) <0.001 367 (±38) 389 (±27) <0.001
142 (±24) 0.016 411 (±34) 382 (±32) 0.128
rameters
144 (±22) 0.548 379 (±33) 384 (±33) 0.247
143 (±25) 0.255 382 (±34) 380 (±33) 0.863
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any of the subjects during the study assessment. How-
ever, no continuous ECG-monitoring was performed. No
comparisons were made between children with fatal and
nonfatal severe malaria because of the low number of
fatalities.
Discussion
Both, changes in the heart rate (tachycardia, bradykar-
dia) as well as cardiac arrhythmias have the potential to
influences cardiocirculatory function and, therefore, to
gain clinical relevance. Children with severe malaria
were tachycardic on the day of admission but the heart
rate declined with the onset of anti-malarial therapy to a
level considered as normal on day 42 reflecting the state
of acute febrile illness and subsequent recovery.
Corrected QT intervals (hQT) were shorter before
therapy than during therapy and also shorter before
therapy compared to after cure. The hQT prolongation
on day 1 was probably at least partially related to quinine
[1]. The data suggest, however, that at least in the youn-
gest children hQT-reduction related to acute disease is
more important in contributing to the observed increase
in QT-time day 0 to day 1 than a potentially drug-related
QT-prolongation on day 1. As day 42 reflects the normal
state in healthy children, the hQT intervals on admission
are not only shorter compared to the situation under
quinine therapy but also shorter in the treatment-naïve
ill child than in the cured child in this age group. This
QT-shortage on day 0 is likely related to the effects of
acute stress and increased sympathetic tone on day 0
and relative improvement of the physical condition one
day after the start of the treatment [1]. These findings
are in line with Adjei et al., who also saw a relative
shortening of pre-treatment QT intervals in children with
uncomplicated malaria [17]. The QRS intervals were
longest on day 1, which can at least partially be ex-
plained by quinine effects. Quinine slows depolarization
by slowing rapid upstroke of cardiac action potential by
blocking sodium inward current (INA) and thereby wid-
ening QRS complex, an effect earlier described in other
studies [18,19] and also seen in this study.
Stratification revealed some age-specific effects on
both heart rate and repolarization. HR was highest in
the youngest and lowest in the oldest children on day 0,
1 and 42, respectively, resembling the physiological
decline of heart rates with age. The age stratified hQT
intervals on day 42, reflecting the healthy status, were
comparable in all age groups confirming the validity
of the applied correcting formula for the QT interval.
Nevertheless, there are differences in the characteristics of
the hQT intervals between the different age groups during
acute disease: In the groups 24 to <48 months of age
and >48 months of age there was a significant prolongationof hQT on day 1 after the start of quinine therapy in
comparison to day 0 as well as to day 42. In the group
of children younger than 24 months of age, on the other
hand, there was no significant difference in hQT intervals
between day 1 and day 42 (Figure 1B). Therefore, the
QT-shortage during acute disease seems the most prom-
inent in the youngest children while quinine related
QT-prolongation becomes increasingly more import-
ant with age. Increased sympathetic tone due to stress,
anxiety and discomfort have been described to increase
heart rate and conduction, resulting in QT shortening
[1]. The iatrogenic effects of the anti-malarial are difficult
to separate from the effect of the underlying disease but
the data suggests a more pronounced effect of the disease
itself rather than the anti-malarial on myocardial electro-
physiology itself. Furthermore, a prolongation of the QRS
intervals on day 1 – likely representing the direct effect of
quinine therapy – could only be shown in age group 24
to <48 months. Van Hensbrook et al. observed that
QRS prolongation after the onset of quinine therapy was
most pronounced in children younger than 24 months
[18]. The data from this study contradict these findings
by revealing an acute disease related QT-shortage rather
than a drug related QT prolongation at least in the
youngest children.
As children younger than 24 months still lack partial
immunity to malaria, the age-dependent differences in
ECG findings might be due to immunity-dependent dif-
ferences in pathophysiology of parasite-host-drug inter-
actions. An earlier study demonstrated an age dependent
effect of plasma nitric oxide (NO) on parasite density in
Ghanaian children with severe malaria with the highest
NO levels in the youngest children [20]. NO is known to
play a key role in regulating cardiac function [21,22].
A relatively high percentage of children had taken
4-aminoquinoline drugs prior to admission. Despite the
change of national policies in 2009 an unexpected high
portion was still treated with chloroquine. Chloroquine is
considered to potentially prolong QT interval [23,24], but
there is no evidence for clinical cardiotoxicity after oral
administration of anti-malarial treatment doses of chloro-
quine [1]. In this study there was no significant difference
between hQT on day 0 in children who had been treated
with chloroquine or amiodiaquine prior to admission to
those who had not been treated – neither for the whole
study group nor for age stratified subgroups. Nevertheless,
there are some interesting findings when comparing
the age-stratified data of hQT for the different groups.
QT-shortage during acute disease in particular in the
youngest and QT-prolongation during quinine treatment in
the elderly were more pronounced in 4-aminoquinoline-
naïve than in pre-treated children.
Of the symptoms and characteristics of severe malaria,
some conditions seem to influence the electrophysiology
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not. Metabolic acidosis - present in one-third of all chil-
dren – as well as respiratory distress and hyperlactatae-
mia were associated with a shortening of hQT intervals.
Respiratory distress as a clinical sign of metabolic acid-
osis was present in most of the acidotic children and
both respiratory distress and acidosis are considered as
independent predictors of fatal outcome in falciparum
malaria [25,26]. How these changes in the electrophysi-
ology of the heart also influence cardiac function is diffi-
cult to say. While an impaired cardiac output in acidotic
children could not be shown in the same study popula-
tion [27] others indeed identified impaired cardiac
function in relation to acidosis [27,28]. Children with
hyperlactataemia and metabolic acidosis also showed
increased HR. These findings can probably be seen as
the overall activation of autonomic nervous system in
severely ill children. While earlier studies showed an
impact of hyperparasitaemia [3] and hypoglycaemia
[29] on corrected QT intervals, the data from this
study does not support these findings. Further, lower
heart rate in children with renal impairment could be
shown but this particular subgroup was too small to
allow a general conclusion from the data.
The study had a number of limitations: a problem
involved the determination of the corrected QT inter-
vals: Many formulas have been proposed to correct QT
intervals for the heart rate [14,15,30,31] but none is com-
pletely satisfying. In this study population of severely ill
children, most heart rates measured were over 100 beats
per minute. As Bazett’s formula overcorrects the QT
interval in high heart rates it was considered as inad-
equate for this study population and it was decided to
use the Wernicke formula developed for children and
adolescents [15]. As normal limits for the paediatric ECG,
including QT intervals, have been described mostly for
Bazett`s formula [32], Bazett corrected QT intervals
(cQT) were still included in some of the analyses to
facilitate comparison to findings in other studies. Com-
paring hQT and cQT showed overall shorter hQT inter-
vals than cQT intervals and thereby demonstrating the
overcorrection of the Bazett’s formula. Even if the Wernicke
seems to be more accurate for this study population
one still has to keep in mind, that effects of age and
gender on the QT interval are described [15,33] and
how error-prone every calculation is as even time of
day, fever, autonomic function and changes in posture
can influence the QT interval [34-37]. Thus, the opti-
mal formula might be hard to find.
Conclusions
In conclusion, the findings suggest that severe malaria
itself is associated with changes in the electrophysiology of
the heart, independent of anti-malarial therapy. Especiallyin young - thus non-immune – children acute malaria-
associated QT-shortage seemed to be more prominent
than anti-malarial-associated QT-prolongation. Neverthe-
less, it remains unclear whether these ECG-changes are of
high clinical relevance as cardiac arrhythmias and subse-
quent circulatory dysfunction does not seem to be a major
contributor to unfavourable outcomes in severe malaria.
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